Neurotherapeutics course offered in Washington, D.C., Feb. 18-21, 2015

The National Institute of Neurological Disorders and Stroke are offering a 3 1/2 day course designed to introduce researchers to the principles of neurotherapeutic drug discovery and development, including the identification of a lead compound and IND enabling studies. The course will also address the unique challenges inherent in developing treatments for nervous system disorders and will address the particular challenges that academic neuroscientists are likely to face in planning and conducting drug discovery research.

February 18-21, 2015
Georgetown University Hotel & Conference Center
Washington, D.C.

The course is directed by:

  • Michael A. Rogawski, M.D., Ph.D., University of California Davis
  • Barbara Slusher, Ph.D., M.A.S., Johns Hopkins Brain Science Institute
  • Marci Glicksman, Ph.D., Brigham and Women’s Hospital and Harvard Medical School
  • Karl Scheidt, Ph.D., Northwestern University

Advanced graduate students, researchers, and faculty at all levels are invited to apply. There is no tuition or registration fee, and travel expenses will be defrayed for all successful applicants. Contact Simone Upsey for more information.